Bruker Corp (OQ:BRKR)

Business Focus: Advanced Medical Equipment & Technology

Mar 11, 2024 07:00 am ET
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows. The rapid advances in deep, at-scale proteomics, glycomics and peptidomics research solutions complement other performance-leading life-science tool
Mar 07, 2024 07:00 am ET
Bruker Announces Closing of Chemspeed Technologies AG Acquisition
Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider of automated laboratory R&D and QC workflow solutions. This acquisition, first announced in January 2024, marks another significant milestone in Bruker’s expansion in vendor-agnostic scientific soft
Feb 28, 2024 07:00 am ET
Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
Bruker Corporation (Nasdaq: BRKR) announced today that it has entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of PAI Partners, a pre-eminent private equity firm, to acquire
Feb 26, 2024 10:42 am ET
Bruker Corporation to Present at Upcoming Investor Conferences
Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences:
Feb 16, 2024 04:05 pm ET
Bruker Announces Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on March 15, 2024 to stockholders of record as of March 1, 2024.
Feb 13, 2024 07:00 am ET
Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2023.
Feb 07, 2024 07:00 am ET
Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Nanophoton Corporation, a pion
Feb 06, 2024 04:05 pm ET
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
Bruker Corporation (Nasdaq: BRKR) today announced that it has acquired Spectral Ins
Feb 06, 2024 07:00 am ET
Bruker Announces Date and Time of Fourth Quarter 2023 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2023 financial results before market opening on Tuesday, February 13, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends.
Feb 05, 2024 07:00 am ET
Jan 25, 2024 07:00 am ET
Bruker Announces Agreement to Acquire Chemspeed
Bruker Corporation (Nasdaq: BRKR) today announced a definitive agreement for the acquisition of Ch
Jan 23, 2024 08:30 am ET
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today the operational readiness of its new proteomics facility in Massachusetts. This US expansion facilitates access to select proteomics contract research organization (CRO) services for our US biopharma customers.
Jan 23, 2024 08:00 am ET
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today the operational readiness of its new proteomics facility in Massachusetts. This US expansion facilitates access to select proteomics...
Jan 04, 2024 08:00 am ET
Bruker Announces Acquisition of Tornado Spectral Systems to Expand Its Biopharma Process Analytical Technology (PAT) Product Portfolio
Bruker (Nasdaq: BRKR) today announced the acquisition of Tornado Spectral Systems Inc., a Canadian co
Jan 03, 2024 04:35 pm ET
Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 42nd annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on
Jan 03, 2024 07:00 am ET
Bruker Acquires Electron Microscopy Company Nion
Bruker today announced that it has acquired Nion, a privately-held company that develops and manufactures innovative high-end scanning transmission electron microscopes (STEM). Nion was the first company to introduce aberration correction for STEM instruments with ultra-high stability for highest resolution images, and Nion is the world leader in ultra-high ener
Dec 19, 2023 09:41 am ET
Bruker Announces First 1.2 GHz NMR Installation in the United States at The Ohio State University - Funded by the U.S. National Science Foundation
Bruker Corporation, the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions for life and materials research, today announced the successful installation of a 1.2 Gigahertz (GHz) NMR system at the National Gateway Ultrahigh Field NMR Center (
Nov 27, 2023 08:15 am ET
Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®
Working together to bring rapid, automated microbial identification directly from positive blood culture samples
Nov 20, 2023 04:15 pm ET
Bruker Announces Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on December 15, 2023 to stockholders of record as of December 1, 2023.
Nov 07, 2023 09:00 am ET
Bruker Corporation to Participate in the 2023 Jefferies London Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2023 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will present and participate in an analyst moderated question and answer session on behalf of the Company on Tuesday, November 14, 2022 at 8:30 AM GMT (3:30 AM Eastern
Nov 02, 2023 07:00 am ET
Bruker Reports Third Quarter 2023 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2023.
Oct 27, 2023 11:07 am ET
Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2023 financial results before market opening on Thursday, November 2, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends.
Oct 04, 2023 07:00 am ET
Bruker Announces Majority Investment in MIRO Analytical AG, an Innovator in Compact, Highest-Precision QCL-Based Multi-Gas Analyzers (MGA)
Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIRO Analytical AG, an
Oct 03, 2023 07:00 am ET
Bruker Completes Acquisition of PhenomeX
Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools, for $108 million in cash. Bruker announced the agreement to acquire PhenomeX on August 17, 2023.
Oct 02, 2023 04:05 pm ET
Bruker Introduces Next-Generation Nanomechanical Test System
At the annual Materials Science and Technology (MS&T23) conference, Bruker Corporation (Nasdaq: BRKR) today announced the release of the
Sep 18, 2023 07:00 am ET
Bruker Introduces Novel 4D-Proteomics™ timsTOF® Capabilities
At the 22nd Human Proteome Organization World Congress 2023, Bruker Corporation (Nasdaq: BRKR) today announced advances in instrumental methods, consumables and software for 4D-Proteomics, MALDI HiPLEX-IHC spatial tissue proteomics, 4D-Lipidomics and 4D-Metabolomics.
Sep 15, 2023 04:06 am ET
Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable for Life Science Research at the HUPO 2023 World Congress
Biognosys, a leading inventor and developer of mass spectrometry (MS)-based proteomics solutions, announced today their attendance at the Human Proteome Organization (HUPO) World Congress from September 17 to September 21 in Busan, South Korea....
Sep 07, 2023 07:00 am ET
Bruker Announces New Fraport AG Framework Contract for ETD Systems
Fraport AG has announced the procurement decision in favor of Bruker for the provision of up to 220 DE-tector™ flex
Sep 06, 2023 07:43 am ET
Dragonfly Energy Leverages Cutting-Edge Lithium Battery Research Instrumentation from Bruker
Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), maker of Battle Born Batteries™ and an industry leader in energy storage, has continued to invest in the development of battery cell manufacturing with...
Aug 24, 2023 04:05 pm ET
Bruker Corporation to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 21st annual Morgan Stanley Global Healthcare Conference in New York City. Gerald Herman, Executive Vice President & CFO will participate in a fireside chat on behalf of the Company on Wednesday, September 13th, 2023 at 4:15 PM Eastern Time.
Aug 17, 2023 09:00 am ET
Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker to acquire PhenomeX for $1.00 per share in an all-cash transaction. The proposed acquisition values PhenomeX at a total equity value of approximately $108 million. PhenomeX is a functional cell biology company that provides single-cell biology research tools to deliver deep insights into cellular function and new perspectives on phenomes and genotype-to-phenotype linkages.
Aug 16, 2023 04:05 pm ET
Bruker to Provide 60 Explosives Trace Detectors for Zuerich Airport
Bruker Corporation today announced that Flughafen Zürich AG in Switzerland has ordered
Aug 14, 2023 07:00 am ET
Bruker Announces Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on September 15, 2023 to stockholders of record as of September 1, 2023.
Aug 03, 2023 07:00 am ET
Bruker Reports Second Quarter 2023 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2023.
Jul 25, 2023 04:44 pm ET
Bruker Announces Date and Time of Second Quarter 2023 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2023 financial results before market opening on Thursday, August 3, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends.
Jul 10, 2023 07:00 am ET
Bruker Enables Advanced Life-Science and Green-Tech Research in the UK
At the EUROMAR Conference 2023 in Scotland, Bruker showcases the latest innovations in magnetic resonance technology for life sc
Jun 30, 2023 07:00 am ET
Bruker Announces SciY™ Platform of Advanced Scientific and Automation Software Solutions for the Digital Transformation of the Life Science and Biopharma Industries
Bruker Corporation (Nasdaq: BRKR) today announced the SciY™ platform of advanced, vendor-agnostic software solutions for data analysis, data management, research lab and bioproduction QC digitalization, and workflow automation in the life science industry and for biopharma companies. The new SciY platform combines and integra
Jun 27, 2023 10:00 am ET
Bruker Announces New D6 PHASERTM Benchtop X-Ray Diffraction (XRD) Platform for Materials Analysis and Advanced Research
Bruker Corporation (Nasdaq: BRKR), the global leader in X-ray diffraction, today announces the new D6 PHASERTM X-Ray Diffraction (XRD) system. The D6 PHASER is a new benchtop XRD platform designed with the analytical flexibility typically only available in larger, floor-standing systems. Unlike conventional, more l
Jun 14, 2023 10:39 am ET
Bruker Releases 2023 Sustainability Report
Bruker Corporation (Nasdaq: BRKR) today released its 2023 Sustainability Report, highlighting how Bruker’s spirit of ‘Innovation with Integrity’ is advancing science and technology, medicine and health, as well as safety and prosperity in a responsible, sustainable manner. The report also provides an overview of Bruker’s ESG strategy, initiatives and pe
Jun 05, 2023 07:00 am ET
Bruker Introduces Novel EVOQ™ DART-TQ+ for Chromatography-Free Mass Spectrometry Aimed at the Applied Market Segments
At the 71st ASMS meeting, Bruker Corporation (Nasdaq: BRKR) highlights its commitment to develop novel technology and improved mass spec workflows for the applied markets requirements of robustness, ease-of-use, and highest confidence in food/beverage, forensic/toxicology, industrial and environmental analysis.
Jun 05, 2023 07:00 am ET
Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300 Hz PASEF MS/MS, and VistaScan™ for Enhanced dia-PASEF® 4D-Proteomics™
At the 71st ASMS meeting, Bruker Corporation (Nasdaq: BRKR) announced transformative sensitivity on the 4D-Proteomics timsTOF platform with the launch of the new timsTOF Ultra mass spectrometer. It incorporates a new Captive Spray Ionization (CSI) Ultra ion source with larger capillary and optimized vortex gas f
Jun 05, 2023 07:00 am ET
PreOmics Introduces New ENRICH-iST Kits and Novel Workflow for Unbiased, Affordable Plasma and Serum Proteomics by LC-MS
At ASMS 2023, PreOmics GmbH announces the launch of its new ENRICH-iST™ kits, which enable biologically unbiased enrichment of lower abundant plasma and serum proteins onto non-functionalized paramagnetic particles, enhancing typical depths of plasma proteomics analysis by 50% to more than 100%, compared to neat plasma or serum proteomics without de
Jun 02, 2023 07:00 am ET
Bruker Corporation to Present at Jefferies 2023 Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will present at the Jefferies 2023 Healthcare Conference in New York on Friday, June 9, 2023 at 9:00 am EDT. Presenting for the company will be Juergen Srega, President of the Bruker CALID Group.
May 31, 2023 04:33 pm ET
Bruker to Host Investor Day on June 15th, 2023
Bruker Corporation (Nasdaq: BRKR) today announced the Company will host an Investor Day on June 15th, 2023, starting at 10:00 AM EDT, at Bruker’s Headquarters located at 40 Manning Road, Billerica, MA, with the live webcast starting at 11:00 AM EDT.
May 15, 2023 04:05 pm ET
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board Declares Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that on May 12, 2023, its Board of Directors approved a new share repurchase authorization for the purchase of up to $500 million of the Company’s common stock over a two-year period commencing on May 15, 2023.
May 08, 2023 07:00 am ET
Bruker Announces Acquisition of ZONTAL to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions
Bruker Corporation (Nasdaq: BRKR) today announced that is has closed the acquisition of ZONTAL Inc. (ww
May 04, 2023 07:00 am ET
Bruker Reports First Quarter 2023 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2023.
Apr 26, 2023 04:05 pm ET
Bruker Announces Date and Time of First Quarter 2023 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2023 financial results before market opening on Thursday, May 4, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends.
Apr 17, 2023 07:00 am ET
Bruker Advances NMR Magnet Portfolio, Innovates in Industrial Solutions
At the Experimental Nuclear Magnetic Resonance Conference (ENC 2023), Bruker announces
Apr 14, 2023 07:00 am ET
Bruker Introduces New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper®, and a Novel LiquidArray® Gastrointestinal Syndromic Panel
At the 33rd European Congress of Clinical Microbiology & Infectious Diseases (www.eccmid.org), Bruker Corporation
Apr 14, 2023 07:00 am ET
PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics
At the AACR Annual Meeting 2023, PreOmics GmbH announced the launch of a BeatBox-based FFPE workflow, which simplifies, speeds up and standardizes FFPE sample preparation for deep, unbiased tissue proteomics by subsequent protein digestion and nanoLC-MS/MS analysis. The novel BeatBox workflow eliminates the need for xylene-based deparaffinization and enabl
Apr 12, 2023 07:00 am ET
Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform
Canopy Biosciences, a Bruker Company, and Enable Medicine, today announced a partnership to provide Enable Medicine’s advanced analysis pipelines for spatial omics data with the Canopy CellScape™ system for quantitative high-plex spatial biology. The partnership will add to the analytic capabilities of the CellScape system by providing options to use Enable Medicine’s advanced spatial analyses, including cluster analysis, neighborhood analysis and advanced data visualization, as well as efficient cloud-based computing, sharing, and data storage.
Mar 17, 2023 07:00 am ET
Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK
Bruker announces that the United Kingdom is expanding its fundamental research infrastructure with recent orders for two 1.2 GHz Avance™ nuclear magnetic resonance (NMR) spectrometers for the
Mar 06, 2023 10:30 am ET
Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization
At the 19th US HUPO, Bruker Corporation (Nasdaq: BRKR) announced important bioinformatics launches for 4D-Proteomics on the timsTOF platform: A novel de novo sequencing algorithm was developed in collaboration with Rapid Novor Inc., using over 1.7 million PASEF data-points to improve accuracy and speed for immunopeptidomics in real-time. The u
Feb 28, 2023 04:04 pm ET
CORRECTING and REPLACING The European Gauss Fusion Initiative Seeks to Use Magnetic Fusion to Ensure a Clean and Safe Energy Supply
Please replace the release with the following corrected version due to multiple revisions.
Feb 28, 2023 02:00 am ET
The European Gauss Fusion Initiative Seeks to Use Magnetic Fusion to Ensure a Clean and Safe Energy Supply
Gauss Fusion GmbH is a greentech venture founded in 2022 by various European companies from Germany, France, Italy and Spain with extensive experience in fusion technology. In February 2023, Gauss Fusion completed a founders’ pre-seed financing round with €8 million in seed capital, marking a first milestone on the way to a clean and secure energy source to complement renewable energies.
Feb 22, 2023 04:15 pm ET
Bruker Corporation to Present at Investor Conferences
Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences:
Feb 17, 2023 07:00 am ET
Bruker Announces Quarterly Dividend
About Bruker Corporation
Feb 09, 2023 07:00 am ET
Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the fiscal year ended December 31, 2022.
Feb 03, 2023 07:00 am ET
Bruker Announces Successful Customer Installations of First Two Compact 1.0 GHz NMR Systems to Advance Structural Biology
Bruker today announced successful customer installations of two novel, compact 1.0 GHz NMR spectrometers for advanced structural and molecular biology applications well ahead of original schedules in late 2022. Both new Ascend Evo 1.0 GHz NMR systems operate at 4.2 Kelvin without subcooling below liquid Helium temperatures, and as a result have ~65% lower liquid Helium consumption than previous 1.0 GHz 2 Kelvin, two-story magnets. These new 1.0 GHz NMR magnets also have significantly reduced footprint, weight, and ceiling height requirements and fit into most single
Jan 31, 2023 04:05 pm ET
Bruker Announces Date and Time of Fourth Quarter 2022 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2022 financial results before market opening on Thursday, February 9, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends.
Jan 05, 2023 04:34 pm ET
Bruker Announces Acquisition of ACQUIFER Imaging GmbH
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy. This acquisition adds high-performance on-premise processing, secure storage and networking technology that complements Bruker’s advanced fluorescence microscopy imagin
Jan 04, 2023 07:00 am ET
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
Biognosys AG and Bruker Corporation (Nasdaq: BRKR) today announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. Financial details were not disclosed. J.P.Morgan acted as exclusive financial advisor...
Jan 04, 2023 07:00 am ET
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
Bruker Corporation (Nasdaq: BRKR) and Switzerland-based Biognosys AG today announced a strategic partnership, in
Dec 21, 2022 04:05 pm ET
Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 41st annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on
Dec 16, 2022 09:47 am ET
Bruker Energy & Supercon Technologies (BEST) Announces Multi-Year Orders for Key Magnetic Confinement Fusion Technologies
Bruker Corporation (Nasdaq: BRKR) announced that its Bruker Energy & Supercon Technologies (BEST) division, and majority-owned RI Research Instruments GmbH (RI) have received multi-year contracts to supply key technology components for major fusion projects in Europe and Asia, together valued at approximately $50 million.
Nov 14, 2022 07:00 am ET
Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio
Bruker Corporation (Nasdaq: BRKR) today announced the signing of the definitive agreement to purchase 100% of the shares of Neurescence Inc., an innovative provider of ultralight fiber-bundle Multiscopes™ for simultaneous multi-region, optical functional neuroimaging. Neurescence’s flagship product Chromatone™ moves illumination and detection hardware off the animal head. This enables simultaneous imaging and stimulation of three sub-types of neurons in up to four regions for flexible investigation of the central nervous system with single-neuron resolution in naturalisti
Nov 11, 2022 07:00 am ET
Bruker Announces Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on December 16, 2022 to stockholders of record as of December 1, 2022.
Nov 08, 2022 07:00 am ET
Bruker Announces Acquisition of Inscopix for Neuroscience Research
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Inscopix, Inc., a neuroscience pioneer and market leader of miniaturized microscopes, known as miniscopes, for freely moving animal brain imaging. Since its founding in 2011, Inscopix's flagship miniscope systems have been deployed in over 600 research institutions and biopharma companies worldwide, empowering breakthroughs in fundamental neuroscience research and advancing the understanding of mechanisms in neurological disorders. This acquisition enhances Bruker’s strong reputation as a technology leader for in-vivo brain f
Nov 07, 2022 04:01 pm ET
Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2022 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will present and participate in an analyst moderated question and answer session on behalf of the Company on Tuesday, November 15, 2022 at 12:00 PM Eastern Time.
Nov 03, 2022 07:00 am ET
Bruker Reports Third Quarter 2022 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2022.
Oct 21, 2022 04:01 pm ET
Bruker Announces Date and Time of Third Quarter 2022 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2022 financial results before market opening on Thursday, November 3, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends.
Aug 29, 2022 06:00 am ET
Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software
At the International Mass Spectrometry Conference (IMSC 2022), Bruker Corporation (Nasdaq: BRKR) today announced the launch of the new nanoElute® 2 nano-LC, of MetaboScape® and TASQ® 2023 software supporting fluxomics, and of latest advances in PaSER™’s intelligent acquisition to enhance research in protein-protein interactions (PPIs) and metaproteom
Aug 22, 2022 07:00 am ET
Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations
At the ICMRBS 2022 Conference, Bruker today announces a new 8 mm 15N TROSY Cryoprobe for enabling novel NMR functional structural biology investigations into larger globular proteins and protein complexes. The new technology also facilitates cell biology research into highly dynamic intrinsically disordered proteins (IDPs) or protei
Aug 12, 2022 07:00 am ET
Bruker Announces Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on September 16, 2022 to stockholders of record as of September 1, 2022.
Aug 03, 2022 04:01 pm ET
Bruker Reports Second Quarter 2022 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2022.
Jul 25, 2022 04:01 pm ET
Bruker Announces Date and Time of Second Quarter 2022 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2022 financial results after market close on Wednesday, August 3, 2022. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends.
Jul 20, 2022 09:00 am ET
Jul 11, 2022 06:00 am ET
Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research
At the Euromar 2022 Conference, Bruker announced three new customer orders for GHz systems, which will incorporate novel, compact 1.0 GHz NMR magnets for structural biology applications and clinical research in single-story laboratories. The new Ascend Evo 1.0 GHz NMR magnet, operating at 4.2 Kelvin, allows functional s
Jul 06, 2022 07:00 am ET
Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID’ Multi-Organ Risk Assessment
Bruker Corporation (Nasdaq: BRKR) today has launched PhenoRisk PACS™ RuO, a research-use-only NMR test for molecular phenomics research on ‘Long COVID’ patients’ blood samples, using a multiplexed combination of biomarkers discovered at the Australian National Phenome Center (ANPC) at Murdoch University, under Director Jeremy Nicholson. The PhenoRisk PACS™ RuO test is promising for research on early-stage risk factors, on longitudinal recovery monitoring and on potential secondary organ damage in cardiovascular disease, type II diabetes,
Jun 21, 2022 07:00 am ET
Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics
At the 18th International Conference of the Metabolomics Society, Bruker Corporation (Nasdaq: BRKR) announced key innovations for spatial multiomics with a focus on unbiased Spatial Single-Cell Metabolomics (SSCM) for probing differential cellular phenotypes based on the metabolic signature of tissues and single cells.
Jun 21, 2022 06:00 am ET
Bruker Presents High-Value Life Science, Materials Research and Applied Market Solutions at Analytica 2022
Bruker Corporation (Nasdaq: BRKR) this week displays its high-value scientific instrumentation, software and integrated solutions for applications in materials and energy research, biopharmaceuticals, applied markets, as well as life science and translational research at Analytica 2022.
Jun 14, 2022 07:00 am ET
Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope
Bruker Corporation (Nasdaq: BRKR) today announced the release of the NeuraLight 3D Ultra™ module to support advanced neuroscience and optogenetics research applications on Bruker’s Ultima multiphoton microscopes. NeuraLight 3D Ultra provides revolutionary 3D holographic photostimulat
Jun 06, 2022 07:00 am ET
Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Field-of-View
At the 70th ASMS Conference, Bruker Corporation (Nasdaq: BRKR) announced key innovations for spatial multiomics of tissue and tumor microenvironments (TME). Following Bruker’s strategic partnership with AmberGen1, key enhancements are introduced for MALDI HiPLEX-IHC mass spectrometry imaging.
Jun 06, 2022 07:00 am ET
Bruker Introduces Novel Point-of-Need Applied Mass Spectrometry Tools for Accelerated Measurements without Chromatography
At ASMS 2022, Bruker Corporation (Nasdaq: BRKR) extends the power of mass spectrometry inside and outside the laboratory to Point-of-Need (PoN) analysis with the introduction of the DART-EVOQ® triple quadrupole mass spectrometer for high-throughput quantitative analyses. The DART-EVOQ does not require chromatography separations for applied markets analysis in food/beverage, forensics, industrial, security, environmental and pharmaceutical workflows.
Jun 06, 2022 07:00 am ET
Bruker Launches timsTOF HT with Greater Dynamic Range for Further Enhancing Unbiased, High-Confidence 4D Proteomics™
At the 70th ASMS meeting, Bruker Corporation (Nasdaq: BRKR) today announced the further evolution of the revolutionary 4D Multiomics timsTOF platform with the launch of the new timsTOF HT system. The timsTOF HT includes a novel 4th-generation TIMS (trapped ion mobility separation) XR cell and 14bit digitizer
May 25, 2022 04:01 pm ET
Bruker Corporation to Present at Jefferies 2022 Global Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will present at the Jefferies 2022 Global Healthcare Conference in New York on Thursday, June 9, 2022 at 3:00 pm EDT. Presenting for the company will be Frank Laukien, President and Chief Executive Officer, and Justin Ward, Sr. Director, Investor Relations & Corporate Development.
May 16, 2022 07:00 am ET
Bruker Announces Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on June 17, 2022 to stockholders of record as of June 1, 2022.
May 10, 2022 07:00 am ET
Bruker and TOFWERK Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial Markets
Bruker Corporation and TOFWERK AG today announced a strategic partnership for high-speed, ultra-sensitive applied and industrial analytical solutions, in conjunction with a Bruker minority investment in TOFWERK.
May 09, 2022 12:52 pm ET
Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets
At the ISMRM 2022 conference, Bruker today announced the launch of innovative 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems portfolio. Following the success of its BioSpec® Maxwell 3 Tesla model, the new range of Maxwell 7 Tesla and 9.4 Tesla magnets eli
May 04, 2022 07:00 am ET
Bruker Reports First Quarter Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2022.
Apr 25, 2022 07:00 am ET
Bruker Demonstrates Novel and Unique Compact 1.0 GHz NMR Magnet
At the Experimental Nuclear Magnetic Resonance Conference (ENC 2022), Bruker demonstrates a novel and remarkably compact 1.0 GHz NMR magnet, operating at 4.2 Kelvin, for structural biology applications in single-story standard laboratories. Bruker also offers innovations and services for reducing liquid helium consumption
Apr 22, 2022 07:00 am ET
Bruker Launches Unique LiquidArray® Multiplex PCR Assays
At the 32nd European Congress of Clinical Microbiology & Infectious Diseases (www.eccmid.org), Bruker Corporatio
Apr 18, 2022 04:05 pm ET
Bruker Announces Date and Time of First Quarter 2022 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2022 financial results before market opening on Wednesday, May 4, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends.
Apr 11, 2022 10:24 am ET
Bruker Announces Key Innovations for Multiplexed Spatial Proteomics and Unbiased Multiomic Imaging for Cancer Research
At the AACR Annual Meeting 2022, Bruker Corporation (Nasdaq: BRKR) launched and exhibited unique and novel capabilities for spatial multiomics, single-cell proteomics, and cell-line, tissue and plasma proteomics cancer research.
Apr 06, 2022 11:00 am ET
IonSense, a Leader In DART™ Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development
IonSense Inc., the innovator of ambient DART™ (Direct Analysis in Real Time) ionization technology, announces that it has been acquired by Bruker Corporation (Nasdaq: BRKR). The deal provides IonSense with the financial investments to ramp up development of the DART ionization source technology and increase efforts in developing applications in the applied markets, including food analysis and forensics.
Apr 05, 2022 07:00 am ET
Apr 04, 2022 07:10 am ET
Bruker Expands dia-PASEF® on the timsTOF 4D Proteomics and Epiproteomics Platform to Identify up to 13,000 Protein Groups with 1% FDR
At the Proteomic Forum | EuPA 2022, Bruker Corporation (Nasdaq: BRKR) announced expanded capabilities for deeper proteomic and epiproteomic coverage, including enhanced phosphopeptide analysis using the innovative TIMScore algorithm, which is now a part of the new PaSER 2022 GPU-based platform. The novel TIMScore al
Mar 16, 2022 09:46 am ET
Bruker Appoints Philip Ma to its Board of Directors
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Philip Ma, Ph.D. to serve on its board, effective as of April 1, 2022.
Mar 10, 2022 09:40 am ET
Announcing New Fourier 80 Benchtop FT-NMR Capabilities for Pharmaceutical and Food Analysis Markets
Bruker Corporation (Nasdaq: BRKR) today announces new capabilities for its benchtop Fourier transform (FT) nuclear magnetic resonance (NMR) spectrometer, the Fourier 80, which does not require special lab infrastructure or cryogens, and offers excellent 1
Mar 03, 2022 02:00 pm ET
Canopy Biosciences Launches Next-Generation ChipCytometry™ Instrument for Spatial Biology with Sub-Cellular Resolution
Canopy Biosciences, a Bruker Company, today announced the commercial launch of the CellScapeTM system, the next generation in ChipCytometryTM instrumentation, advancing the cutting-edge for quantitative in situ spatial phenotyping. ChipCytometry delivers single-cell targeted spatial proteomics f
Mar 02, 2022 11:15 am ET
Newomics and Bruker Announce Collaborations on High-throughput Bioanalysis
Newomics Inc., a biotechnology company commercializing mass spectrometry solutions for molecular detection, and
Feb 28, 2022 11:05 am ET
Bruker Releases CCS-Enabled TIMScore™ and TIMS DIA-NN 4D Proteomics Software
At US HUPO, Bruker Corporation (Nasdaq: BRKR) announced its TIMS DIA-NN software for the high-throughput, deep and unbiased 4D proteomics workflow. It now features the novel TIMScore algorithm which takes advantage of machine learning (ML) to predict CCS values of tryptic and phosphorylated peptides. With TIMScore, the measured CCS valu
Feb 28, 2022 07:00 am ET
Bruker Corporation to Present at Cowen’s 42nd Annual Health Care Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in Cowen’s 42nd Annual Health Care Conference which is taking place virtually on March 7 - 9, 2022. Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, March 7th, 2022 at 2:50 PM Eastern Standard Time.
Feb 18, 2022 07:00 am ET
Bruker Announces Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on March 18, 2022 to stockholders of record as of March 1, 2022.
Feb 11, 2022 07:00 am ET
Bruker Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the fiscal year ended December 31, 2021.
Feb 10, 2022 07:00 am ET
Bruker Corporation to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 11th Annual SVB Leerink Global Healthcare Conference, being held virtually. Frank Laukien, Chairman, President & CEO will present on behalf of the Company on Wednesday, February 16th, 2022 at 8:40 AM Eastern Standard Time.
Feb 07, 2022 07:01 am ET
Bruker Enables High-Throughput Multiplex HTS on Sierra SPR Platform
At the SLAS2022 International Conference and Exhibition, Bruker Corporation (Nasdaq: BRKR) is announcing a multiplexed assay taking high-throughput screening with SPR to the next level. The innovative microfluidic system of the Bruker Sierra SPR-32 Pro provides a unique 8x4 array for parallel readout of 32 measurement sensor spo
Feb 07, 2022 07:00 am ET
Bruker Launches New timsTOF-based MALDI PharmaPulse® Solution for Label-free HTS in Drug Discovery
At the SLAS2022 International Conference and Exhibition, Bruker Corporation (Nasdaq: BRKR) today announced the launch of its timsTOF MALDI PharmaPulse® (timsTOF MPP) system, a groundbreaking new high-end solution for unbiased, deep HTS and uHTS based on label-free mass spectrometry.
Feb 04, 2022 07:00 am ET
Bruker Expands Nanoflow Consumables Portfolio for 4D-Proteomics™
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of PepSep, a Danish company specializing in nanoflow liquid chromatography (nanoLC) columns, specialty emitters and components to optimize nanoflow proteomics workflows, which are extensively used in Bruker’s nanoElute® UHPLC system. Financial terms of the tran
Feb 02, 2022 07:00 am ET
Bruker Announces Date and Time of Fourth Quarter 2021 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2021 financial results before market opening on Friday, February 11, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends.
Jan 19, 2022 07:00 am ET
Bruker Acquires Prolab Instruments to Augment Multiomics Solutions
Established in 1988, ProLab’s innovations center around micro and nano-UHPLC pump technology, resulting in the development of the unique Zirconium™ split-less pump technology for flow rates from nano-flow (4-800 nL/min) to cap-flow (1-10 µL/min) regimes. The Zirconium™ Ultra nano- and cap-UHPLC system supports a broad range of flow rates from 4 nL/min to 10 µL/min at 1000 bar (15,000 psi), and is suitable for cap-LC in high-throughput proteomics and metabolomics.
Jan 04, 2022 07:00 am ET
Bruker Corporation to Present at the 40th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 40th annual J.P. Morgan Healthcare Conference, to be held virtually on January 10-13, 2022. Frank Laukien, Chairman, President & CEO and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 10th, 2022 at 9:
Dec 20, 2021 07:00 am ET
Bruker Introduces Fast BioAFM for Automated Mechanobiology
Bruker today announced the release of the JPK NanoWizard® V BioAFM, a novel system that marks a milestone in automation and ease of use for life science atomic force microscopy research. NanoWizard V is a very fast, automated BioAFM that can optionally be fully integrated with advanced optical
Dec 08, 2021 07:00 am ET
Bruker Announces $500 Million Private Placement of Senior Notes to Support Strategic Growth Objectives
Bruker Corporation (Nasdaq: BRKR) announced today that it has completed a new private placement of 10-year senior notes in the aggregate principal amount of $500 million to enhance its financial flexibility and fund strategic growth objectives.
Dec 02, 2021 11:43 am ET
Bruker Expects its FluoroType® SARS-CoV-2 varID Q PCR Assay to Reliably Detect and Tentatively Differentiate Omicron (B.1.1.529) Variant
Bruker Corporation (Nasdaq: BRKR) today announced that its established CE-IVD marked FluoroType® SARS-CoV-2 varID Q real-time multiplexed PCR assay reliably detects all SARS-CoV-2 variants, and in addition is expected to also provide a clear indication of Omicron (B.1.1.529), recently declared a ‘variant of concern’ by the WHO.
Nov 24, 2021 05:51 pm ET
Bruker BioSciences Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600
NEW YORK, Nov. 24, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the opening of trading on Thursday, December 2:
Nov 19, 2021 07:00 am ET
Bruker Announces Acquisition of MOLECUBES NV
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems. This acquisition strengthens Bruker’s position as a leading NMI solutions provider in preclinical and translational imaging research.
Nov 16, 2021 07:00 am ET
Bruker Announces Collaborative Advances in CCS-Enabled 4D Proteomics Workflows at HUPO
At the virtual 20th Human Proteome Organization World Congress, HUPO Reconnect 2021 (hupo2021.org) Bruker C
Nov 15, 2021 07:00 am ET
Bruker Announces Fourth Quarter 2021 Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock. The dividend will be paid on December 17, 2021 to stockholders of record as of December 1, 2021.
Nov 09, 2021 07:00 am ET
Bruker Corporation to Participate in the 2021 Jefferies London Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will participate in an analyst-moderated question and answer session on behalf of the Company on Tuesday, November 16, 2021 at 12:20 PM GMT.
Nov 02, 2021 07:00 am ET
Bruker Announces Major Advances in CCS-Enabled 4D Proteomics at ASMS
At the 69th ASMS meeting in Philadelphia, Bruker Corporation (Nasdaq: BRKR) announced novel CCS-enabled 4D proteomics for major capability enhancements for timsTOF Pro 2, timsTOF fleX and timsTOF SCP mass spectrometers.
Nov 01, 2021 04:05 pm ET
Bruker Reports Third Quarter 2021 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2021.
Oct 18, 2021 04:10 pm ET
Bruker Announces Date and Time of Third Quarter 2021 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2021 financial results on Monday, November 1, 2021, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends.
Oct 01, 2021 07:00 am ET
NSF-Funded Network for Advanced NMR Orders Two 1.1 GHz NMR Systems to Advance Protein Structure and Dynamics Research
Bruker Corporation (Nasdaq: BRKR) today announced that it has received orders for two 1.1 GHz NMR Avance Neo systems from U.S. academic institutions funded by the National Science Foundation (NSF). NSF awarded the funds to establish the Network for Advanced NMR (NAN) linkin
Aug 30, 2021 04:10 pm ET
Bruker Corporation to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Wells Fargo Virtual Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer, and Falko Busse, President of the Bruker BioSpin Group, will participate in an analyst moderated question and answer session on behalf of the Company on Friday, Se
Aug 06, 2021 07:00 am ET
Bruker Announces Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock. The dividend will be paid on September 17, 2021 to stockholders of record as of September 1, 2021.
Aug 02, 2021 04:05 pm ET
Bruker Reports Second Quarter 2021 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2021.
Jul 21, 2021 07:00 am ET
Bruker Announces Date and Time of Second Quarter 2021 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2021 financial results on Monday, August 2, 2021, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends.
Jun 21, 2021 08:00 am ET
Novel 4D-Metabolomics and 4D-Lipidomics Workflows, Libraries and ML-based CCS Prediction Tools to Transform Metabolomics and Lipidomics
At Bruker’s virtual 4D-Metabolomics™ eXceed Symposium (eXceed Symposia 4D-Metabolomics 2021 | Bruker),
Jun 17, 2021 08:00 am ET
Bruker Updates FY 2021 Guidance and Provides Medium Term Outlook at Virtual Investor Day
At its 2021 Virtual Investor Day today, Bruker Corporation (Nasdaq: BRKR) will discuss the Company’s strategy and Project Accelerate 2.0 initiatives, including the Company’s potential high-growth opportunities in the areas of proteomics and spatial biology. Bruker will also update its fiscal year 2021 guidance and will discuss its medium term financial
Jun 07, 2021 08:00 am ET
Bruker to Host Virtual Investor Day on June 17th, 2021
Bruker Corporation (Nasdaq: BRKR) will host a Virtual Investor Day on June 17th, 2021, starting at 10:00 AM Eastern Daylight Time. The Investor Day will be in a virtual format, with no option to attend in person.
Jun 07, 2021 07:00 am ET
Bruker Launches CE-IVD Quantitative Coronavirus Mid-Plex PCR Assay with Mutation Detection for Routine Variant Differentiation
Bruker Corporation (Nasdaq: BRKR) today announced the launch of the FluoroType SARS-CoV-2 varID Q assay – a quantitative LiquidArray® mid-plex PCR panel. This novel assay panel also detects several important mutations to enable laboratories and hospitals to differentiate many major viral variants routinel
Jun 01, 2021 07:00 am ET
Bruker Launches timsTOF trueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth
At Bruker’s virtual 4D-Proteomics™ eXceed Symposium (eXceed Symposia 2021 | Bruker), Br
May 20, 2021 10:12 am ET
Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities
A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute COVID-19 disease phase. These biochemical abnormalities, identified by a quantitative, label-free assay platform integrating nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), relate to ongoing ‘long COVID’ symptoms, which persist post-acute infection and can affect more than half of the recovered COVID patients - even six months after infect
May 13, 2021 08:32 am ET
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board also Declares Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that on May 12, 2021, its Board of Directors approved a new share repurchase authorization for the purchase of up to $500 million of the Company’s common stock over a two-year period commencing on May 13, 2021.
May 13, 2021 08:00 am ET
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board also Declares Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that on May 12, 2021, its Board of Directors approved a new share repurchase authorization for the purchase of up to $500 million of the Company’s common stock over a two-year period commencing on May 13, 2021.
May 10, 2021 07:14 am ET
International Organization of Vine and Wine (OIV) Officially Incorporates NMR Method in Compendium of International Methods of Analysis of Wines and Musts
Nuclear magnetic resonance (NMR) spectroscopy has been incorporated by the intergovernmental and International Organization of Vine and Wine (OIV) in its compendium of International Methods of Analysis of Wines and Musts, for the quantification of six key parameters in wine – glucose, malic acid, acetic acid, fumaric acid, shikimic acid and s
May 07, 2021 07:00 am ET
Bruker Corporation to Present at Investor Conferences
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the following virtual conferences:
May 05, 2021 07:00 am ET
Bruker Reports First Quarter 2021 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2021.
Apr 13, 2021 04:10 pm ET
Bruker Announces First Quarter 2021 Preliminary Revenue
Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2021 in a range of $549 - $554 million, representing reported revenue growth of approximately 30% to 31%, compared to the first quarter of 2020. Adjusting for the impact of foreign currency translation and acquisitions, Bruker estimates non-GAAP o
Mar 29, 2021 07:00 am ET
Gigahertz-class NMR Opens New Scientific Windows on Functional Structural Biology in Neurodegenerative Disease and Aging Research
At the Experimental Nuclear Magnetic Resonance Conference 2021 (ENC), Bruker Corporation (Nasdaq: BRKR) announces
Mar 26, 2021 07:00 am ET
Bruker Makes Routine Magnetic Resonance Spectroscopy More Broadly Accessible for Chemical Analysis Outside Central Labs
Just prior to the 2021 Experimental Nuclear Magnetic Resonance Conference (www.enc-conference.org), Bruker Corporation (Nasdaq: BRKR) is making chemical analysis by magnetic resonance spectroscopy more broadly accessible beyond the central lab. Bruker’s new magnetic resonance systems are intended for pharma, chemical and food research and
Mar 24, 2021 07:00 am ET
Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center
Bruker Corporation (Nasdaq: BRKR), a leading supplier of single-plane illumination microscopy (SPIM) technology for research on live cells and cleared biological samples, today announced that two Luxendo
Mar 18, 2021 07:00 am ET
Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics
Acuity Spatial Genomics, Inc. today announced the completion of a majority investment by Bruker Corporation (Nasdaq: BRKR). Acuity is a new venture focused on opening a new frontier in spatial 3D genomics and multiomic analyses for discovery. The novel technology platform of Acuity Spatial Genomics, enabled by an exclusive license to innovations from Harvard University, allows progress in genome-wide visualization of spatially resolved 3D chromatin architecture in individual cells and cell populations in situ. The company’s single-cell technology of OligoFISSEQ™ and accelerated super-re
Mar 08, 2021 09:22 am ET
Feb 25, 2021 08:41 am ET
New Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurements and Deep Learning for 4D Proteomics
Bruker Corporation (Nasdaq: BRKR) today announces a seminal publication from the groups of Professors Matthias Mann and Fabian Theis in the journal Nature Communications with the title ‘Deep learning the collisional cross sections of the peptide universe from a million experimental values’ by Florian Meier et al. (
Feb 22, 2021 07:00 am ET
Bruker Corporation to Present at Investor Conferences
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the following virtual conferences:
Feb 18, 2021 07:00 am ET
Bruker Announces Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock. The dividend will be paid on March 19, 2021 to stockholders of record as of March 5, 2021.
Feb 16, 2021 07:00 am ET
Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the fiscal year ended December 31, 2020.
Feb 02, 2021 04:05 pm ET
Bruker Announces Date and Time of Fourth Quarter 2020 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2020 financial results on Tuesday, February 16, 2021, before the market opens. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends.
Jan 07, 2021 07:00 am ET
GHz-Class NMR Opens New Scientific Research Window for Discoveries and Novel Insights in Functional Structural Biology and Disease Biology
Bruker Corporation (Nasdaq: BRKR) today announced that three world-leading institutions are now accelerating their research into functional structural biology and human disease with new Bruker ultra-high field nuclear magnetic resonance (NMR) spectrometers installed in 2020. Novel GHz-class NMR technology enables advanced research to obtain structural,
Jan 06, 2021 07:00 am ET
Bruker Corporation to Present at the 39th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 39th annual J.P. Morgan Healthcare Conference, to be held virtually on January 11-14, 2021. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO will present on behalf of the Company on Monday, January 11th, 2021 at 3:40 PM Eastern Standard T
Jan 05, 2021 07:00 am ET
Bruker and Evosep Announce Major Progress in Unbiased, Quantitative True Single-cell Proteomics
Bruker Corporation (Nasdaq: BRKR) and Evosep today announced major progress in high-sensitivity, quantitative true
Jan 04, 2021 07:00 am ET
Bruker Introduces MBT Sepsityper® Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultures
Dr. Wolfgang Pusch, Executive Vice President Microbiology & Diagnostics at Bruker Daltonics, stated: “This represents an order of magnitude increase in the number of microorganisms that can be identified rapidly from positive blood cultures in suspected bacterial or fungal sepsis cases compared to targeted PCR detection. This could make the MBT Sepsityper Kit US IVD a nearly universal, rapid sepsis identification solution for clinical microbiology. We expect this affordable fast assay to benefit large numbers of patients, as it comes at a fraction of the cost of expensive syndrom
Dec 18, 2020 07:00 am ET
Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark
Bruker Corporation (Nasdaq: BRKR) today announced the launch of the FluoroType SARS-CoV-2/Flu/RSV winter four-plex PCR panel, which enables the sensitive and simultaneous detection of the SARS-CoV-2 virus, of both influenza A and B viruses, as well as of the respiratory syncytial virus (RSV). In the winter season, multiple viruses need
Nov 16, 2020 07:30 am ET
Bruker Corporation to Participate in the Jefferies Virtual London Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the Jefferies Virtual London Healthcare Conference. Gerald Herman, Chief Financial Officer, will participate in an analyst moderated question and answer session on behalf of the company on Wednesday, November 18, 2020 at 2:05 PM Greenwich Mean Time (9:05 AM Eastern Standard Time
Nov 13, 2020 07:00 am ET
Bruker Announces Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock. The dividend will be paid on December 18, 2020 to stockholders of record as of December 1, 2020.
Nov 02, 2020 04:05 pm ET
Bruker Reports Third Quarter 2020 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2020.
Oct 21, 2020 07:00 am ET
Oct 20, 2020 07:00 am ET
Bruker Announces Date and Time of Third Quarter 2020 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2020 financial results on Monday, November 2, 2020, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends.
Oct 19, 2020 07:00 am ET
Oct 19, 2020 06:00 am ET
Bruker Introduces PaSER™ Software for ‘Run and Done’ 4D- ProteomicsTM and TIMS/PASEF Method Wins HUPO 2020 Award
At the virtual 19th Human Proteome Organization World Congress (hupo2020.org), Bruke
Sep 30, 2020 07:00 am ET
Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational Studies
Bruker Corporation (Nasdaq: BRKR) announces the recent acquisition of the Integrated Proteomics Pipeline (IP2) search engine and proteomics workflow software platform. IP2 was developed by Integrated Proteomics Applications Inc, a company founded by leading proteomics researcher Professor John Yates III, together with Drs. Robin Park a
Sep 11, 2020 07:00 am ET
Bruker Announces Acquisition of Canopy Biosciences, LLC
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques. Bruker’s global reach, complementary technologies and a
Sep 08, 2020 07:00 am ET
Bruker Appoints Bonnie H. Anderson to its Board of Directors
Bruker Corporation (Nasdaq: BRKR) today announced that it has appointed Bonnie H. Anderson to serve on its board of directors, effective as of September 3, 2020.
Sep 04, 2020 07:00 am ET
Bruker Corporation to Participate in the 2020 Wells Fargo Virtual Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2020 Wells Fargo Virtual Healthcare Conference. Frank Laukien, Chairman, President & CEO will participate in an analyst moderated question and answer session on behalf of the company on Thursday, September 10, 2020 at 11:20 AM Eastern Time.
Aug 10, 2020 07:00 am ET
Bruker Supports International Covid19-NMR Consortium for Structure-Function and Inhibitor Binding Investigations of SARS-CoV-2 RNA and Proteins
Bruker Corporation (Nasdaq: BRKR) today announced its support of a worldwide collaborative project that investigates the structures, dynamics, function and binding of SARS-CoV-2 viral RNA and proteins using high-field nuclear magnetic resonance (NMR) spectroscopy. The Covid19-NMR (
Aug 07, 2020 08:00 am ET
Bruker Announces Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock. The dividend will be paid on September 18, 2020 to stockholders of record as of September 1, 2020.
Aug 07, 2020 07:00 am ET
Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry
Bruker Corporation (Nasdaq: BRKR) today announced a collaboration with Utrecht University to advance the study of the 3-D structures and interactions of proteins by mass spectrometry. The laboratory of Albert Heck at Utrecht University has been a leader in proteomics and the study of protein structure and interactions by mass spectrometry for over two d
Aug 03, 2020 04:05 pm ET
Bruker Reports Second Quarter 2020 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2020.
Jul 30, 2020 07:00 am ET
Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule Applications
Bruker Corporation (Nasdaq: BRKR) today announced the release of the Nano
Jul 27, 2020 07:00 am ET
Bruker Launches Second-Generation FluoroType® SARS-CoV-2 plus PCR Test for Detection of SARS-CoV-2 Viral Infections in Europe
Bruker Corporation (Nasdaq: BRKR) today announced the launch of the FluoroType® SARS-CoV-2 plus next-generation 6-plex PCR assay for the highly specific detection of the SARS-CoV-2 virus, which causes the respiratory and systemic disease COVID-19 (CV19).
Jul 22, 2020 08:30 am ET
Successful Installation of ETH 1.2 GHz NMR System Enables Novel Research Capabilities in Solid-State NMR
Bruker Corporation (Nasdaq: BRKR) today announced the successful installation and customer acceptance of the
Jul 20, 2020 04:10 pm ET
Bruker Announces Date and Time of Second Quarter 2020 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2020 financial results on Monday, August 3, 2020, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends.
May 29, 2020 07:00 am ET
Bruker Introduces Breakthrough MALDI-2 Source on timsTOF fleX, and Further Innovations in CCS-Enabled 4D Proteomics on timsTOF
At the virtual ASMS 2020 Reboot conference, Bruker Corporation (Nasdaq: BRKR) today announces a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world’s first commercial MALDI-2 post-ionization (PI) source, which is now available as an option on the timsTOF fleX™ ESI/MALDI mass spectrometer. Th
May 13, 2020 07:00 am ET
Bruker Announces Quarterly Dividend
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock. The dividend will be paid on June 19, 2020 to stockholders of record as of June 1, 2020.
May 12, 2020 04:10 pm ET
Bruker Corporation to Present at Virtual Investor Conferences
Bruker Corporation (Nasdaq: BRKR) announced today it will present at the following virtual conferences:
May 11, 2020 08:00 am ET
Bruker Announces Virtual Meeting Option for the Company’s 2020 Annual Stockholders Meeting
Bruker Corporation (Nasdaq: BRKR) today announced that it is adding a virtual meeting option to its 2020 Annual Meeting of Stockholders as a result of continuing concerns surrounding the COVID-19 pandemic. The Annual Meeting will be held on Thursday, May 21, 2020 at 10:00 a.m., Eastern Time, at the offices of Morgan, Lewis & Bockius LLP, One Federal
May 06, 2020 04:05 pm ET
Bruker Reports First Quarter 2020 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2020.
May 04, 2020 07:00 am ET
Successful Installation of World’s First 1.2 GHz NMR System Enables Novel Functional Structural Biology Research
Bruker Corporation (Nasdaq: BRKR) today announced the successful installation and customer acceptance of the world’s first Avance™ NEO 1.2 GHz NMR system at the CERM (www.cerm.unifi.it) of the University of Florence. CERM is an Italian center of the European research infrastructure in structural biology, called Instru
Apr 22, 2020 07:00 am ET
Bruker Announces Date and Time of First Quarter 2020 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2020 financial results on Wednesday, May 6, 2020, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends.
Apr 17, 2020 12:34 pm ET
SHAREHOLDER ALERT: Lowey Dannenberg Investigates Claims on Behalf of Investors of Bruker Corporation (BRKR)
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors is investigating possible violations of federal securities laws on behalf of investors of Bruker Corporation (“Bruker” or the “Company”) (NASDAQ: BRKR)....
Apr 12, 2020 02:34 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR
NEW YORK, April 12, 2020 /CNW/ -- Pomerantz LLP is investigating claims on behalf of investors of Bruker Corporation ("Bruker" or the "Company") (NASDAQ: BRKR).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Apr 12, 2020 02:34 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR
NEW YORK, April 12, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bruker Corporation ("Bruker" or the "Company") (NASDAQ: BRKR).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Apr 01, 2020 07:00 am ET
Bruker Highlights New Analytical Systems and Applied Market Solutions
Bruker Corporation (Nasdaq: BRKR) this week highlights new analytical systems and high-value solutions for biopharma and forensics applications, as well as for industrial process control and materials science research. Originally, Bruker had planned to launch these products at Analytica 2020 this week. However, with conferences and tradeshows postponed
Mar 31, 2020 08:00 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Bruker Corporation (BRKR) Investors Who Have Suffered Losses to Contact its Attorneys: Investigation Into Possible Securities Law Violations Ongoing
Hagens Berman urges investors in Bruker Corporation (NASDAQ: BRKR) who have suffered significant losses to submit their losses now.  The firm is investigating possible securities law violations, and certain investors may have valuable claims....
Mar 27, 2020 05:05 pm ET
Bruker Announces Final Fourth Quarter and Fiscal Year 2019 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced final audited financial results for the fourth quarter and fiscal year 2019, and the filing of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The Company’s Audit Committee with the assistance of independent, external legal counsel and independent forensic accountants has c
Mar 27, 2020 12:00 pm ET
The Law Offices of Frank R. Cruz Continues Its Investigation on Behalf of Bruker Corporation Investors (BRKR)
The Law Offices of Frank R. Cruz continues its investigation on behalf of Bruker Corporation ("Bruker" or the "Company") (NASDAQ:
Mar 27, 2020 11:45 am ET
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Bruker Corporation and Encourages Investors with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bruker Corporation (“Bruker” or “the Company”) (NASDAQ:
Mar 26, 2020 03:19 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Bruker Corporation and Encourages Investors with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bruker Corporation (“Bruker” or “the Company”) (NASDAQ:
Mar 26, 2020 12:00 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Bruker Corporation (BRKR) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Bruker Corporation ("Bruker" or the "Company") (NASDAQ:
Mar 26, 2020 10:21 am ET
EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Announces Investigation of Securities Claims Against Bruker Corporation – BRKR
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Bruker Corporation (NASDAQ: BRKR) resulting from allegations that Bruker may have issued materially misleading business information to the investing public.
Mar 26, 2020 08:17 am ET
Block & Leviton LLP Continues to Investigate Bruker Corp. for Possible Securities Laws Violations; Investors Who Lost Money Should Contact the Firm
Block & Leviton LLP (www.blockesq.com), a national securities litigation firm, continues to investigate potential claims against Bruker Corporation (NASDAQ: BRKR) and certain of its officers for potential securities fraud.  Investors who have lost...
Mar 25, 2020 08:05 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Bruker Corporation (BRKR) Investors Who Have Suffered Losses to Contact its Attorneys: Investigation Into Possible Securities Law Violations Ongoing
Hagens Berman urges investors in Bruker Corporation (NASDAQ: BRKR) who have suffered significant losses to submit their losses now.  The firm is investigating possible securities law violations, and certain investors may have valuable claims....
Mar 25, 2020 12:00 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Bruker Corporation (BRKR) on Behalf of Investors
Law Offices of Howard G. Smith continues its investigation on behalf Bruker Corporation ("Bruker" or the "Company") (NASDAQ: BRKR) investors concerning the Company and its officers’ possible violations of federal securities laws.
Mar 24, 2020 04:05 pm ET
Bruker Announces Launch of CE-IVD Marked genesig® Assay Kit for the Detection of the SARS-CoV-2 Virus
The genesig® real-time PCR Coronavirus (COVID-2019) CE-IVD assay is validated for use on Bruker-Hain Diagnostics GenoXtract® (GXT) automated nucleic acid extraction devices with associated extraction kits. Shipments to Spain, France, Germany and the UK have already started.
Mar 09, 2020 07:00 am ET
New Functional Structural Biology Capabilities Enabled by Bruker GHz-Class NMR Technology
At the Experimental Nuclear Magnetic Resonance Conference 2020 (ENC), Bruker Corporation (Nasdaq: BRKR) announces the recent delivery of the world’s first Avance™ NEO 1.2 GHz NMR system to the CERM at the University of Florence, Italy, and the first installation of an Avance NEO 1.1 GHz system at S
Mar 06, 2020 04:57 pm ET
The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Bruker Corporation Investors (BRKR)
The Law Offices of Frank R. Cruz announces an investigation on behalf of Bruker Corporation ("Bruker" or the "Company") (NASDAQ:
Mar 06, 2020 02:05 pm ET
BRUKER CORPORATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Bruker Corporation on Behalf of Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Bruker Corporation (NASDAQ: BRKR) on behalf of Bruker stockholders. Our investigation concerns whether Bruker has violated the federal securities laws and/or engaged in other unlawful business practices.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.